Using a selective inhibitor of CD73 activity (PSB12379, 10 μM) [32], we show that inhibition of CD73 in the whole blood of CLL patients increased ADP-induced platelet activation as measured by the increase in active αIIbβ3 expression (Figure 3D). Here, NT5E is linked to B-cell chronic lymphocytic leukemia.